Výsledky vyhledávání - "Seminars in oncology"

Upřesnit hledání
  1. 1

    KRAS mutation in pancreatic cancer Autor Luo, Ji

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.02.2021
    Vydáno v Seminars in oncology (01.02.2021)
    “…Pancreatic cancer is a recalcitrant cancer with one of the lowest 5-year survival rates. A hallmark of pancreatic cancer is the prevalence of oncogenic…”
    Zjistit podrobnosti o přístupu
    Journal Article
  2. 2

    Ovarian Cancer: An Integrated Review Autor Stewart, Christine, Ralyea, Christine, Lockwood, Suzy

    ISSN: 0749-2081, 1878-3449, 1878-3449
    Vydáno: United States Elsevier Inc 01.04.2019
    Vydáno v Seminars in oncology nursing (01.04.2019)
    “…To provide an overview of the risk factors, modifiable and non-modifiable, for ovarian cancer as well as prevention, diagnostic, treatment, and long-term…”
    Získat plný text
    Journal Article
  3. 3

    Multiple myeloma epidemiology and survival: A unique malignancy Autor Kazandjian, Dickran

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.12.2016
    Vydáno v Seminars in oncology (01.12.2016)
    “…Multiple myeloma (MM), although a rare disease, is the second most common hematologic malignancy. It is found in the spectrum of plasma cell dyscrasias, which…”
    Zjistit podrobnosti o přístupu
    Journal Article
  4. 4

    Modern radiotherapy for head and neck cancer Autor Alterio, Daniela, Marvaso, Giulia, Ferrari, Annamaria, Volpe, Stefania, Orecchia, Roberto, Jereczek-Fossa, Barbara Alicja

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.06.2019
    Vydáno v Seminars in oncology (01.06.2019)
    “…Radiation therapy (RT) plays a key role in curative-intent treatments for head and neck cancers. Its use is indicated as a sole therapy in early stage tumors…”
    Zjistit podrobnosti o přístupu
    Journal Article
  5. 5

    Cancer and the Immune System: The History and Background of Immunotherapy Autor Abbott, Maura, Ustoyev, Yelena

    ISSN: 0749-2081, 1878-3449, 1878-3449
    Vydáno: United States Elsevier Inc 01.10.2019
    Vydáno v Seminars in oncology nursing (01.10.2019)
    “…This article will outline the link between the immune system and cancer, and provide a historical timeline of immunotherapy developmental milestones. Published…”
    Získat plný text
    Journal Article
  6. 6

    Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development Autor Wilde, Lindsay, Roche, Megan, Domingo-Vidal, Marina, Tanson, Katherina, Philp, Nancy, Curry, Joseph, Martinez-Outschoorn, Ubaldo

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.06.2017
    Vydáno v Seminars in oncology (01.06.2017)
    “…Glucose is a key metabolite used by cancer cells to generate ATP, maintain redox state and create biomass. Glucose can be catabolized to lactate in the…”
    Zjistit podrobnosti o přístupu
    Journal Article
  7. 7

    The Next Hurdle in Cancer Immunotherapy: Overcoming the Non-T-Cell-Inflamed Tumor Microenvironment Autor Gajewski, Thomas F

    ISSN: 1532-8708
    Vydáno: United States 01.08.2015
    Vydáno v Seminars in oncology (01.08.2015)
    “…A growing body of evidence suggests that a major subset of patients with advanced solid tumors shows evidence for a T-cell-inflamed tumor microenvironment…”
    Zjistit podrobnosti o přístupu
    Journal Article
  8. 8

    Cervical Cancer: An Overview of Pathophysiology and Management Autor Johnson, Cynae A., James, Deepthi, Marzan, Amelita, Armaos, Mona

    ISSN: 0749-2081, 1878-3449, 1878-3449
    Vydáno: United States Elsevier Inc 01.04.2019
    Vydáno v Seminars in oncology nursing (01.04.2019)
    “…To provide an overview of the etiology, prevention, diagnosis, treatment, and long-term survivorship concerns surrounding cervical cancer. A review of articles…”
    Získat plný text
    Journal Article
  9. 9

    Implications of reactive oxygen species on cancer formation and its treatment Autor Shah, Manish A, Rogoff, Harry A

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.06.2021
    Vydáno v Seminars in oncology (01.06.2021)
    “…Elevated levels of reactive oxygen species (ROS) are a hallmark of cancer. Although increased ROS concentrations play important roles in cancer formation and…”
    Zjistit podrobnosti o přístupu
    Journal Article
  10. 10

    A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab Autor Fessas, Petros, Lee, Hassal, Ikemizu, Shinji, Janowitz, Tobias

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.04.2017
    Vydáno v Seminars in oncology (01.04.2017)
    “…T-cell checkpoint inhibition has a profound impact on cancer care and the programmed cell death protein 1 (PD-1)-targeted antibodies nivolumab and…”
    Zjistit podrobnosti o přístupu
    Journal Article
  11. 11

    Axillary surgery in breast cancer: An updated historical perspective Autor Magnoni, Francesca, Galimberti, Viviana, Corso, Giovanni, Intra, Mattia, Sacchini, Virgilio, Veronesi, Paolo

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.12.2020
    Vydáno v Seminars in oncology (01.12.2020)
    “…This historical surgical retrospection focuses on the temporal de-escalation axillary surgery, focusing on the unceasing efforts of researchers toward new…”
    Zjistit podrobnosti o přístupu
    Journal Article
  12. 12

    PARP1 roles in DNA repair and DNA replication: The basi(c)s of PARP inhibitor efficacy and resistance Autor Kanev, Petar-Bogomil, Atemin, Aleksandar, Stoynov, Stoyno, Aleksandrov, Radoslav

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.02.2024
    Vydáno v Seminars in oncology (01.02.2024)
    “…Genome integrity is under constant insult from endogenous and exogenous sources. In order to cope, eukaryotic cells have evolved an elaborate network of DNA…”
    Zjistit podrobnosti o přístupu
    Journal Article
  13. 13

    Cancer and the Immune System: Basic Concepts and Targets for Intervention Autor Pardoll, Drew

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.08.2015
    Vydáno v Seminars in oncology (01.08.2015)
    “…A number of consensuses regarding cancer immunology have recently emerged from both preclinical immunotherapy models and analysis of cancer patients. First and…”
    Zjistit podrobnosti o přístupu
    Journal Article
  14. 14

    Antagonists of PD-1 and PD-L1 in Cancer Treatment Autor Lipson, Evan J, Forde, Patrick M, Hammers, Hans-Joerg, Emens, Leisha A, Taube, Janis M, Topalian, Suzanne L

    ISSN: 1532-8708
    Vydáno: United States 01.08.2015
    Vydáno v Seminars in oncology (01.08.2015)
    “…The PD-1 pathway, comprising the immune cell co-receptor Programmed Death 1 (PD-1) and its ligands, PD-L1 (B7-H1) and PD-L2 (B7-DC), mediates local…”
    Zjistit podrobnosti o přístupu
    Journal Article
  15. 15

    Epidemiology and Overview of Gliomas Autor Davis, Mary Elizabeth

    ISSN: 0749-2081, 1878-3449, 1878-3449
    Vydáno: United States Elsevier Inc 01.12.2018
    Vydáno v Seminars in oncology nursing (01.12.2018)
    “…To present an overview of gliomas, review risk factors, and prognostic and predictive biomarkers. Published manuscripts and textbook chapters. Molecular…”
    Získat plný text
    Journal Article
  16. 16

    Managing the adverse events associated with lenvatinib therapy in radioiodine-refractory differentiated thyroid cancer Autor Cabanillas, Maria E, Takahashi, Shunji

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.02.2019
    Vydáno v Seminars in oncology (01.02.2019)
    “…Lenvatinib is a multikinase inhibitor of vascular endothelial growth factor (VEGF) receptors 1-3, fibroblast growth factor receptors 1-4, RET, KIT, and…”
    Zjistit podrobnosti o přístupu
    Journal Article
  17. 17

    PARP inhibitors: A review of the pharmacology, pharmacokinetics, and pharmacogenetics Autor Zeng, Yi, Arisa, Oluwatobi, Peer, Cody J, Fojo, Antonio, Figg, William D

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.02.2024
    Vydáno v Seminars in oncology (01.02.2024)
    “…PARP inhibitors have emerged as a promising class of anticancer agents approved for the treatment of ovarian, breast, prostate, and pancreatic cancer. These…”
    Zjistit podrobnosti o přístupu
    Journal Article
  18. 18

    Invasive lobular breast cancer: A review of pathogenesis, diagnosis, management, and future directions of early stage disease Autor Thomas, Mathew, Kelly, Erinn Downs, Abraham, Jame, Kruse, Megan

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.04.2019
    Vydáno v Seminars in oncology (01.04.2019)
    “…Invasive lobular carcinoma (ILC) is the second most common type of invasive breast cancer after invasive ductal carcinoma (IDC). Invasive lobular carcinoma has…”
    Zjistit podrobnosti o přístupu
    Journal Article
  19. 19

    Cancer stem cells: the promise and the potential Autor Ajani, Jaffer A, Song, Shumei, Hochster, Howard S, Steinberg, Ira B

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.04.2015
    Vydáno v Seminars in oncology (01.04.2015)
    “…Despite the advancement of treatment modalities, many cancer patients experience tumor recurrence and metastasis at regional or distant sites. Evolving…”
    Zjistit podrobnosti o přístupu
    Journal Article
  20. 20

    Chemotherapy-induced peripheral neuropathy and rehabilitation: A review Autor Zhang, Shangming

    ISSN: 1532-8708, 1532-8708
    Vydáno: United States 01.06.2021
    Vydáno v Seminars in oncology (01.06.2021)
    “…Chemotherapy-induced peripheral neuropathy (CIPN) is a common complication after chemotherapy that can damage the sensory, motor, autonomic, or cranial nerves…”
    Zjistit podrobnosti o přístupu
    Journal Article